Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: The Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial

American Heart Journal

Volumn 156, Issue 4, 2008, Pages 776-782

  Rudnick, Michael R ^a,f   Davidson, Charles ^b,f   Laskey, Warren ^c,f   Stafford, J Lawrence ^d,f   Sherwin, Paul F ^e,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e GE HEALTHCARE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; IODIXANOL; IOVERSOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; KIDNEY ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OSMOLARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TRIIODOBENZOIC ACIDS;

EID: 53149101647     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.05.023     Document Type: Article

References (22)

1. Hou S.H., Bushinsky D.A., Wish J.B., et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 74 (1983) 243-248
2. Rudnick M.R., Goldfarb S., Wexler L., et al. for the Iohexol Cooperative Study. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47 (1995) 254-261
3. Katzberg R.W., and Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl 69 (2006) S3-S7
4. Jones C.A., McQuillan G.M., Kusek J.W., et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32 (1998) 992-999
5. McClennan B.L. Low-osmolality contrast media: premises and promises. Radiology 162 (1987) 1-8
6. Barrett B.J., and Carlisle E.J. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
7. Heyman S.N., and Rosen S. Dye-induced nephropathy. Semin Nephrol 23 (2003) 477-485
8. Aspelin P., Aubry P., Ransson S.G., et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
9. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
10. Durham J.D., Caputo C., Dokko J., et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62 (2002) 2202-2207
11. Allaqaband S., Tumuluri R., Malik A.M., et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for the prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Intervent 57 (2002) 279-283
12. Boccalandro F., Amhad M., Smalling R.Q., et al. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Cathet Cardiovasc Intervent 58 (2003) 336-341
13. Webb J.G., Pate G.E., Humphries K.J., et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 148 (2004) 422-429
14. Humes H.D., Hunt D.A., and White M.D. Direct toxic effect of the radiocontrast agent diatrizoate on proximal tubule cells. Am J Physiol 252 (1987) F246-F255
15. Heyman S.N., Rosen S., and Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 2 (1994) 153-157
16. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
17. Jo S.-H., Youn T.-J., Koo B.-K., et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 924-930
18. Barrett B.J., Katzberg R.W., Thomsen H.S., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography. A double-blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815-821
19. Solomon R.J., Natarajan M.K., Doucet S., et al. Cardiac angiography in renally impaired patients (CARE) study. A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115 (2007) 3189-3196
20. Solomon R. The role of osmolality in the incidence of contrast induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 68 (2005) 2256-2263
21. McCullough P.A., Bertrand M.E., Brinker J.A., et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
22. Briguori C., Colombo A., Airoldi F., et al. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int 68 (2005) 2250-2255